ANDA 91030, held by West-Ward Pharm Corp. Cefotetan Disodium.
As of Nov 16, 2026, ANDA 91030 (Cefotetan), held by West-Ward Pharm Corp, was first approved by FDA on Oct 26, 2011, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 26, 2011 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| CefotetanEQ 10GM BASE/VIAL ยท injectable;injection | Cefotetan Disodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters